ROIV - Arbutus Biopharma jumps after patent victory in fight with Moderna
2024-04-03 12:27:33 ET
More on Arbutus Biopharma
- Arbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call Transcript
- Arbutus Biopharma GAAP EPS of -$0.44 beats by $0.01, revenue of $18.1M misses by $3.04M
- Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute
- Seeking Alpha’s Quant Rating on Arbutus Biopharma
- Historical earnings data for Arbutus Biopharma